Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CWD NASDAQ:FTHM NASDAQ:INTG NYSE:RFL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCWDCaliberCos$4.02+2.9%$4.18$1.63▼$48.00$18.43M-0.452.55 million shs141,089 shsFTHMFathom$1.73-2.8%$1.84$0.65▼$3.37$55.14M1.82290,371 shs308,264 shsINTGIntergroup$30.62+13.3%$17.18$9.57▼$40.99$66.97M0.153,756 shs24,923 shsRFLRafael$1.39+6.5%$1.46$1.28▼$3.19$48.60M0.85135,427 shs96,967 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCWDCaliberCos+1.83%-7.36%-49.15%+39.78%-68.65%FTHMFathom+10.56%+5.33%-36.88%+29.93%-32.83%INTGIntergroup+12.44%+36.82%+37.63%+143.51%+75.75%RFLRafael-2.02%-1.13%-2.96%-38.93%-43.78%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCWDCaliberCos$4.02+2.9%$4.18$1.63▼$48.00$18.43M-0.452.55 million shs141,089 shsFTHMFathom$1.73-2.8%$1.84$0.65▼$3.37$55.14M1.82290,371 shs308,264 shsINTGIntergroup$30.62+13.3%$17.18$9.57▼$40.99$66.97M0.153,756 shs24,923 shsRFLRafael$1.39+6.5%$1.46$1.28▼$3.19$48.60M0.85135,427 shs96,967 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCWDCaliberCos+1.83%-7.36%-49.15%+39.78%-68.65%FTHMFathom+10.56%+5.33%-36.88%+29.93%-32.83%INTGIntergroup+12.44%+36.82%+37.63%+143.51%+75.75%RFLRafael-2.02%-1.13%-2.96%-38.93%-43.78%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCWDCaliberCos 1.50ReduceN/AN/AFTHMFathom 2.00Hold$2.5039.88% UpsideINTGIntergroup 1.00SellN/AN/ARFLRafael 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest CWD, INTG, FTHM, and RFL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/14/2025INTGIntergroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/13/2025FTHMFathomRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$2.00 ➝ $2.5010/13/2025CWDCaliberCosZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold10/8/2025CWDCaliberCosWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025FTHMFathomWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025RFLRafaelWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025CWDCaliberCosWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025FTHMFathomWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025INTGIntergroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025RFLRafaelWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)8/15/2025CWDCaliberCosZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCWDCaliberCos$32.32M0.56N/AN/A$10.02 per share0.39FTHMFathom$335.18M0.17N/AN/A$1.98 per share0.90INTGIntergroup$64.38M1.01$0.40 per share74.94($53.06) per share-0.57RFLRafael$640K74.02N/AN/A$3.51 per share0.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCWDCaliberCos-$19.78M-$18.00N/A65.92N/A-64.81%-75.95%-11.44%11/11/2025 (Estimated)FTHMFathom-$21.58M-$1.06N/AN/AN/A-6.04%-53.57%-29.66%11/6/2025 (Estimated)INTGIntergroup-$5.35M-$2.47N/A∞N/A-8.31%N/A-5.01%N/ARFLRafael-$34.41M-$0.94N/A∞N/A-3,127.60%-24.75%-21.12%11/5/2025 (Estimated)Latest CWD, INTG, FTHM, and RFL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/11/2025N/ACWDCaliberCos-$0.32N/AN/AN/A$4.48 millionN/A11/6/2025Q3 2025FTHMFathom-$0.10N/AN/AN/A$102.12 millionN/A9/30/2025Q4 2025INTGIntergroupN/A-$0.76N/A-$0.76N/A$16.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCWDCaliberCosN/AN/AN/AN/AN/AFTHMFathomN/AN/AN/AN/AN/AINTGIntergroupN/AN/AN/AN/AN/ARFLRafaelN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCWDCaliberCosN/A0.500.50FTHMFathom0.211.201.20INTGIntergroupN/A0.950.95RFLRafaelN/A3.853.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCWDCaliberCos4.06%FTHMFathom55.49%INTGIntergroup3.36%RFLRafael11.30%Insider OwnershipCompanyInsider OwnershipCWDCaliberCos42.50%FTHMFathom16.40%INTGIntergroup74.10%RFLRafael10.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCWDCaliberCos744.60 million2.64 millionNot OptionableFTHMFathom24031.87 million26.64 millionOptionableINTGIntergroup302.15 million558,000Not OptionableRFLRafael2035.09 million31.51 millionOptionableCWD, INTG, FTHM, and RFL HeadlinesRecent News About These CompaniesUpdate: Terra Clean Energy Corp. Enters into Definitive Agreements to Acquire Uranium Claims on The San Rafael Swell, Utah, United StatesSeptember 24, 2025 | globenewswire.comTerra Clean Energy Corp. Enters into Definitive Agreements to Acquire Uranium Claims on The San Rafael Swell, Utah, United StatesSeptember 24, 2025 | globenewswire.comRafael Holdings Inc.September 17, 2025 | barrons.comRafael announces data from Cyclo Therapeutics’ Phase 3 TransportNPC studySeptember 16, 2025 | msn.comTerra Clean Energy Corp. Announces Agreement to Earn 100% Interest in 75 Past Producing Uranium Claims on The San Rafael Swell, Utah, United StatesSeptember 16, 2025 | thenewswire.comTRafael Holdings, Inc. Reports Promising 48-Week Data on Trappsol® Cyclo™ Treatment for Niemann-Pick Disease Type C1 at ICIEM 2025September 16, 2025 | quiverquant.comQRafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years OldSeptember 16, 2025 | globenewswire.comRafael Holdings, Inc. Subsidiary Cyclo Therapeutics to Present New Data on Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 at ICIEM 2025August 27, 2025 | quiverquant.comQRafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)August 27, 2025 | globenewswire.comNew Photo of Rafael Nadal and Roger Federer Emerges on TuesdayJuly 26, 2025 | msn.comRafael Leao pays heartfelt tribute to Diogo Jota as Milan beat LiverpoolJuly 26, 2025 | msn.comRafael Leao, Kenny Dalglish and Hong Kong crowd honor Diogo Jota in Liverpool preseason friendlyJuly 26, 2025 | msn.comRafael Leao's touching tribute to Diogo Jota vs Liverpool as club make statementJuly 26, 2025 | mirror.co.ukMRafael Devers makes his debut at first base for Giants after refusing to play position for Red SoxJuly 25, 2025 | sfexaminer.comSRafael Devers Player Props: July 25, Giants vs. MetsJuly 25, 2025 | sportsbookwire.usatoday.comWatch: Roger Federer visits Rafael Nadal's AcademyJuly 18, 2025 | msn.comKaiser Lays Off Dozens Of Nurses In Petaluma, San Rafael: ReportJuly 18, 2025 | msn.comGolf: Packed field for 4th annual San Rafael City ChampionshipJuly 18, 2025 | marinij.comMGiants Boss Says It's 'Just a Matter of Time' Until Rafael Devers Catches FireJuly 18, 2025 | msn.comRafael Leao hits back after more bitter Cassano criticismJuly 18, 2025 | sports.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCWD, INTG, FTHM, and RFL Company DescriptionsCaliberCos NASDAQ:CWD$4.01 +0.12 (+2.95%) As of 02:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Caliber (NASDAQ: CWD) is a vertically integrated alternative asset management firm whose purpose is to build generational wealth for investors seeking to access opportunities in middle-market assets. Caliber differentiates itself by creating, managing, and servicing proprietary products, including middle-market investment funds, private syndications, and direct investments which are managed by our in-house asset services group. Our funds include investment vehicles focused primarily on real estate, private equity, and debt facilities. Additional information can be found at Caliberco.com and CaliberFunds.co.Fathom NASDAQ:FTHM$1.73 -0.05 (-2.81%) As of 02:34 PM EasternFathom Holdings Inc. provides a real estate services platform that integrates residential brokerage, mortgage, title, and insurance services in the United States. It operates through three segments: Real Estate Brokerage, Mortgage, and Technology. The Real Estate Brokerage segment provides real estate brokerage services. The Mortgage segment offers residential loan origination and underwriting services. The Technology segment provides Software as a Service solutions and data mining for third party customers. It offers access to various properties for sale or lease through its FathomRealty.com website to buyers, sellers, landlords, and tenants; insurance agency services; and title services. In addition, the company provides intelliAgent, a real estate technology platform that offers a suite of brokerage and agent level tools, technology, business processes, business intelligence and reporting, and training; transaction, personnel, customer relationship, and accounting management for agent transactions; and reporting, social media marketing, and other marketing and marketing repository services, as well as marketplace for add-on services and third-party technology. Its brands include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, Verus Title, and Cornerstone. The company was founded in 2010 and is headquartered in Cary, North Carolina.Intergroup NASDAQ:INTG$30.62 +3.59 (+13.26%) As of 03:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The InterGroup Corporation, through its subsidiaries, operates a hotel under the Hilton San Francisco Financial District name located in San Francisco, California. The company operates through three segments: Hotel Operations, Real Estate Operations, and Investment Transactions. Its hotel consists of guest rooms and luxury suites, a restaurant, a lounge, a private dining room, meeting room space, a gym, a grand ballroom, 5-level underground parking garage, a pedestrian bridge, and a Chinese culture center. The company also invests in income-producing instruments, corporate debt and equity securities, publicly traded investment funds, mortgage-backed securities, securities issued by REITs, and other companies that invest primarily in real estate. In addition, it owns, manages, and invests in apartment complexes, single-family houses as strategic investments, and commercial real estate property located in the United States, as well as owns unimproved land in Maui, Hawaii. The InterGroup Corporation was founded in 1965 and is based in Los Angeles, California.Rafael NYSE:RFL$1.38 +0.09 (+6.54%) As of 02:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability 3 Healthcare Companies Insiders Are Buying Tempus AI Hits $100—Are Shares Due for a Pullback? NVIDIA Analysts Lift Targets: What It Means for the Stock Price Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Why Congress Is Buying Intuitive Surgical Ahead of Earnings D-Wave: Reevaluating the Short Seller’s Case After the Downgrade Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
